Dysregulation of GLT-1-mediated glutamate transport precedes amyloid plaque formation and neuronal dysfunction and accelerates neurodegeneration in AD mouse models [26,27,28,29]. This evidence concerns the gene SLC1A2 and Alzheimer disease.